Douglas D. Richman

77.5k total citations · 27 hit papers
509 papers, 55.6k citations indexed

About

Douglas D. Richman is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Douglas D. Richman has authored 509 papers receiving a total of 55.6k indexed citations (citations by other indexed papers that have themselves been cited), including 390 papers in Virology, 347 papers in Infectious Diseases and 140 papers in Epidemiology. Recurrent topics in Douglas D. Richman's work include HIV Research and Treatment (389 papers), HIV/AIDS drug development and treatment (282 papers) and HIV/AIDS Research and Interventions (239 papers). Douglas D. Richman is often cited by papers focused on HIV Research and Treatment (389 papers), HIV/AIDS drug development and treatment (282 papers) and HIV/AIDS Research and Interventions (239 papers). Douglas D. Richman collaborates with scholars based in United States, United Kingdom and France. Douglas D. Richman's co-authors include Diane V. Havlir, Celsa A. Spina, Susan J. Little, Margaret A. Fischl, Paul A. Volberding, Huldrych F. Günthard, Joseph K. Wong, Donna M. Jacobsen, Martin Hirsch and Scott M. Hammer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Douglas D. Richman

504 papers receiving 53.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1997 2.4k citations Douglas D. Richman, Robert F. Siliciano et al. profile →
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 2.3k citations Douglas D. Richman et al. profile →
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1997 1.7k citations Joseph K. Wong, Huldrych F. Günthard et al. profile →
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 1.5k citations John W. Mellors, Douglas D. Richman et al. profile →
Antiretroviral Treatment of Adult HIV Infection

2012 1.4k citations Douglas D. Richman, Donna M. Jacobsen et al. profile →
HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy

1989 1.3k citations Douglas D. Richman et al. profile →
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

1987 975 citations Douglas D. Richman et al. profile →
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection

1990 951 citations Richard C. Reichman, William D. Hardy et al. profile →
Rapid evolution of the neutralizing antibody response to HIV type 1 infection

2003 896 citations Douglas D. Richman, Susan J. Little et al. Proceedings of the National Academy of Sciences profile →
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

2012 878 citations Douglas D. Richman, Ronald J. Bosch et al. profile →
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

2002 878 citations Susan J. Little, John W. Mellors et al. profile →
Antiretroviral Therapy in Adults

2000 874 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
Antiretroviral Therapy for HIV Infection in 1998

1998 837 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
Antiretroviral Treatment of Adult HIV Infection

2008 832 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

1997 782 citations Douglas D. Richman et al. Nature Medicine profile →
Treatment for Adult HIV Infection

2006 767 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

2000 742 citations Celsa A. Spina, Douglas D. Richman et al. profile →
The Challenge of Finding a Cure for HIV Infection

2009 664 citations Douglas D. Richman et al. profile →
Treatment for Adult HIV Infection

2004 601 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
Antiretroviral Treatment of Adult HIV Infection

2010 595 citations Huldrych F. Günthard, Donna M. Jacobsen et al. profile →
Antiretroviral Treatment for Adult HIV Infection in 2002

2002 573 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
Defective proviruses rapidly accumulate during acute HIV-1 infection

2016 515 citations Katherine M. Bruner, Alexandra J. Murray et al. Nature Medicine profile →
A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study

1991 509 citations Albert W. Wu, Haya R. Rubin et al. Medical Care profile →
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

1994 487 citations Douglas D. Richman, Stephen A. Spector et al. Journal of Virology profile →
Highly Precise Measurement of HIV DNA by Droplet Digital PCR

2013 413 citations Matthew C. Strain, Steven M. Lada et al. profile →
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant

2013 385 citations Matthew C. Strain, Douglas D. Richman et al. profile →
2015 update of the drug resistance mutations in HIV-1

2015 288 citations Vincent Cálvez, Victoria A. Johnson et al. PubMed profile →

Peers

Countries citing papers authored by Douglas D. Richman

Since Specialization

Citations

This map shows the geographic impact of Douglas D. Richman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas D. Richman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas D. Richman more than expected).

Fields of papers citing papers by Douglas D. Richman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas D. Richman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas D. Richman. The network helps show where Douglas D. Richman may publish in the future.

Co-authorship network of co-authors of Douglas D. Richman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas D. Richman. A scholar is included among the top collaborators of Douglas D. Richman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas D. Richman. Douglas D. Richman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance 2025 ·Clinical Infectious Diseases ·Annemarie M. J. Wensing, Charlotte Charpentier, Vincent Cálvez, Francesca Ceccherini‐Silberstein, Huldrych F. Günthard, Donna M. Jacobsen, Roger Paredes, Robert W. Shafer, Douglas D. Richman	6
2	Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study 2020 ·PLoS Medicine ·Lucas E. Hermans, Sergio Carmona, Monique Nijhuis, Hugo A. Tempelman, Douglas D. Richman, Michelle Moorhouse, Diederick E. Grobbee, François Venter, Annemarie M. J. Wensing	36
3	Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size 2019 ·PLoS Computational Biology ·Daniel I. S. Rosenbloom, Peter Bacchetti, Mars Stone, Xutao Deng, Ronald J. Bosch, Douglas D. Richman, Janet D. Siliciano, John W. Mellors, Steven G. Deeks, Roger G. Ptak, Rebecca Hoh, Sheila M. Keating, (unknown), Marta Massanella, Jun Lai, Michele D. Sobolewski, Deanna A. Kulpa, Michael P. Busch, (unknown)	17
4	Encyclopedia of AIDS 2018 ·Thomas J. Hope, Douglas D. Richman, Mario Stevenson	6
5	Improved assays to measure and characterize the inducible HIV reservoir 2018 ·EBioMedicine ·Marta Massanella, Christina Yek, Steven M. Lada, Masato Nakazawa, (unknown), (unknown), Douglas D. Richman	38
6	Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement 2018 ·Science Immunology ·Giuseppe Lofano, Matthew J. Gorman, Ashraf S. Yousif, Wen‐Han Yu, Julie M. Fox, Anne‐Sophie Dugast, Margaret E. Ackerman, Todd J. Suscovich, Joshua A. Weiner, Dan H. Barouch, Hendrik Streeck, Susan J. Little, Davey M. Smith, Douglas D. Richman, Douglas A. Lauffenburger, Bruce D. Walker, Michael Diamond, Galit Alter	66
7	Defective proviruses rapidly accumulate during acute HIV-1 infection breakdown → 2016 ·Nature Medicine ·Katherine M. Bruner, Alexandra J. Murray, Ross A. Pollack, Mary Soliman, Sarah B. Laskey, Adam A. Capoferri, Jun Lai, Matthew C. Strain, Steven M. Lada, Rebecca Hoh, Ya‐Chi Ho, Douglas D. Richman, Steven G. Deeks, Janet D. Siliciano, Robert F. Siliciano	515
8	2015 Update of the Drug Resistance Mutations in HIV-1. 2016 ·PubMed ·Annemarie M. J. Wensing, Vincent Cálvez, Huldrych F. Günthard, Victoria A. Johnson, Roger Paredes, Deenan Pillay, Robert W. Shafer, Douglas D. Richman	56
9	2017 Update of the Drug Resistance Mutations in HIV-1. 2016 ·PubMed ·Annemarie M. J. Wensing, Vincent Cálvez, Huldrych F. Günthard, Victoria A. Johnson, Roger Paredes, Deenan Pillay, Robert W. Shafer, Douglas D. Richman	149
10	Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection 2016 ·Journal of Virology ·Sara Gianella, Christy M. Anderson, Susanna R. Var, Michelli F. Oliveira, Steven M. Lada, Milenka V. Vargas, Marta Massanella, Susan J. Little, Douglas D. Richman, Matthew C. Strain, Josué Pérez‐Santiago, Davey M. Smith	55
11	The future of HIV-1 therapeutics : resistance is futile? 2015 ·Springer eBooks ·Bruce E. Torbett, David S. Goodsell, Douglas D. Richman	2
12	Probing chelation motifs in HIV integrase inhibitors 2012 ·Proceedings of the National Academy of Sciences ·Arpita Agrawal, (unknown), (unknown), Kasthuraiah Maddali, (unknown), Douglas D. Richman, Yves Pommier, Seth M. Cohen	40
13	Update of the Drug Resistance Mutations in HIV-1: December 2010 2010 ·PubMed ·Victoria A. Johnson, Françoise Brun‐Vézinet, Bonaventura Clotet, Huldrych F. Günthard, Daniel R. Kuritzkes, Deenan Pillay, Douglas D. Richman, (unknown)	71
14	Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C 2008 ·Journal of Virology ·James Μ. Binley, (unknown), Emma T. Crooks, Michael S. Seaman, Elin S. Gray, Katie L. Davis, Julie M. Decker, Diane Wycuff, Linda Harris, Natalie Hawkins, Blake Wood, (unknown), Douglas D. Richman, Georgia D. Tomaras, Frédéric Bibollet‐Ruche, James E. Robinson, Lynn Morris, George M. Shaw, David C. Montefiori, John R. Mascola	278
15	Genetic attributes of cerebrospinal fluid-derived HIV-1 env 2006 ·Brain ·Satish K. Pillai, Sergei L. Kosakovsky Pond, Yang Liu, Benjamin M. Good, Matthew C. Strain, Ronald J. Ellis, Scott Letendre, Davey M. Smith, Huldrych F. Günthard, Igor Grant, Thomas D. Marcotte, J. Allen McCutchan, Douglas D. Richman, Joseph K. Wong	84
16	Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. 1997 ·Journal of Clinical Investigation ·Celsa A. Spina, Harry E. Prince, Douglas D. Richman	155
17	Resistance, Drug Failure, and Disease Progression 1994 ·Aids Patient Care ·Douglas D. Richman	3
18	HIV Drug Resistance 1992 ·AIDS Research and Human Retroviruses ·Douglas D. Richman	67
19	A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study breakdown → 1991 ·Medical Care ·Albert W. Wu, Haya R. Rubin, William C. Mathews, John E. Ware, (unknown), William D. Hardy, Samuel A. Bozzette, Stephen A. Spector, Douglas D. Richman	509
20	Treatment of Recurrent Genital Herpes Simplex Infections with Oral Acyclovir. A Controlled Trial 1984 ·Obstetrical & Gynecological Survey ·Richard C. Reichman, Gary J. Badger, Grégory Mertz, Lawrence Corey, Douglas D. Richman, James D. Connor, (unknown), (unknown), Michael N. Oxman, (unknown), (unknown), J. Portnoy, (unknown), Ronald E. Keeney, Takamaru Ashikaga, Raphael Dolin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact